Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: The BAN study

Journal of Clinical Virology

Volumn 54, Issue 4, 2012, Pages 318-320

  Chasela, Charles S ^a,b,c   Wall, Patrick ^b   Drobeniuc, Jan ^d   King, Caroline C ^d   Teshale, Eyasu ^d   Hosseinipour, Mina C ^a   Ellington, Sascha R ^d   Codd, Mary ^b   Jamieson, Denise J ^d   Knight, Rodney J ^e   Fitzpatrick, Patricia ^b   Kourtis, Athena P ^d   Hoffman, Irving F ^f   Kayira, Dumbani ^a   Mumba, Noel ^a   Kamwendo, Deborah D ^a   Martinson, Francis ^a   Powderly, William ^b   van der Horst, Charles ^f   Kamili, Saleem ^d  

^a UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Principia International   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

HCV; HIV; Malawi; Pregnant women

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; ASSAY; CHEMOLUMINESCENCE; COMORBIDITY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNORADIOMETRIC ASSAY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALAWI; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RECOMBINANT IMMUNOBLOT ASSAY; SCREENING TEST; VIRUS HEPATITIS;

ADOLESCENT; ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; MALAWI; MASS SCREENING; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RNA, VIRAL; YOUNG ADULT;

EID: 84863876607     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.05.003     Document Type: Article

References (17)

1. Alter M.J. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007, 13(17):2436-2441.
2. Alter M.J. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006, 44(1 Suppl):S6-S9.
3. Modi A., Field J. Viral hepatitis and HIV in Africa. AIDS Rev 2007, 9:25-39.
4. Ahmed S.D., Cuevas L.E., Brabin B.J. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infection Dis 1998, 37(3):248-251.
5. Sutcliffe S., Taha T.E., Kumwenda N.I., Taylor E., Liomba G.N. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Acquir Immune Defic Syndrome 2002, 31(1):90-97.
6. Maida M.J., Costello D.C., Hoffman I., Cohen M.S., Kumwenda M., Vernazza P.L. Prevalence of Hepatitis C infection in Malawi and lack of association with sexually transmitted diseases. Eur J Epidemiol 2000, 16:1183-1184.
7. Candotti D., Mundy C., Kadewele G., Nkhoma W., Bates I., Allain J.P. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses. J Medical Virol 2001, 65(1):1-5.
8. Nyirenda M., Beadsworth M.B.J., Stephany P., Hart C.A., Hart I.J., Munthali C. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect 2008, 57(1):72-77.
9. Moore E., Beadsworth M.B., Chaponda M., Mhango B., Faragher B., Njala J., et al. Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection. J Infect 2010, 61(2):155-163.
10. Thio C.L., Seaberg E.C., Skolasky R., Phair J., Visscher B., Munoz A., et al. HIV-1, Hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet 2002, 360(9349):1921-1926.
11. Agwale S.M., Tanimoto L.W., Chad Odama L.L., Odama L., Leung K., Duey D., et al. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol 2004, 31(Suppl 1):3-6.
12. van der Horst C., Chasela C., Ahmed Y., Hoffman I., Hosseinipour M., Knight R., et al. Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials 2009, 30(1):24-33.
13. Chasela C.S., Jamieson D.J., Kayira D., Kayira D., Hosseinipour M., Kourtis A.P., et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010, 362:2271-2281.
14. Alter M.J., Kuhnert W.L., Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003, 52(RR-3):1-13.
15. Rouet F., Chaix M.L., Inwoley A., Msellati P., Viho I., Combe P., et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. J Med Virol 2004, 74(1):34-40.
16. Hladik W. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 2006, 11(6):951-954.
17. Pirillo M.E., Bassani L., Germinario E.A.P., Mancini M.G., Vyankandondera J., Okong P., et al. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol 2007, 79(12):1797-1801.